FDA Label for Pramipexole Dihydrochloride
View Indications, Usage & Precautions
Pramipexole Dihydrochloride Product Label
The following document was submitted to the FDA by the labeler of this product Zydus Lifesciences Limited. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Package Label.Principal Display Panel
NDC 70771-1328-3
Pramipexole Dihydrochloride Extended-release Tablets, 0.375 mg
Rx only
30 tablets
NDC 70771-1329-3
Pramipexole Dihydrochloride Extended-release Tablets, 0.75 mg
Rx only
30 tablets
NDC 70771-1330-3
Pramipexole Dihydrochloride Extended-release Tablets, 1.5 mg
Rx only
30 tablets
NDC 70771-1331-3
Pramipexole Dihydrochloride Extended-release Tablets, 2.25 mg
Rx only
30 tablets
NDC 70771-1332-3
Pramipexole Dihydrochloride Extended-release Tablets, 3 mg
Rx only
30 tablets
NDC 70771-1333-3
Pramipexole Dihydrochloride Extended-release Tablets, 3.75 mg
Rx only
30 tablets
NDC 70771-1334-3
Pramipexole Dihydrochloride Extended-release Tablets, 4.5 mg
Rx only
30 tablets
* Please review the disclaimer below.